Table 3 Treatment for DSM-IV 12-mo MDD, according to clinical severity, among those with any 12-month contact coverage (N = 164); São Paulo Metropolitan Area, Brazil
Any 12-month contact coverage | 12-Mo DSM-IV MDD | F (p-value) | |||||
|---|---|---|---|---|---|---|---|
Severe (n = 90) | Mild/Moderate (n = 74) | Any severity (n = 164) | |||||
n | % (SE) | n | % (SE) | n | % (SE) | ||
Any psychotropic medication | 66 | 71.0 (5.4) | 39 | 54.8 (6.7) | 105 | 63.6 (3.1) | 2.30 (0.14) |
Any antidepressants | 47 | 47.2 (6.7) | 26 | 40.1 (7.7) | 73 | 43.9 (5.2) | 0.51 (0.48) |
Adequate medication control | 43 | 48.0 (7.0) | 21 | 37.4 (7.4) | 64 | 43.1 (4.9) | 0.95 (0.34) |
Adequate pharmacotherapy | 25 | 26.3 (5.7) | 12 | 22.9 (7.4) | 37 | 24.8 (4.6) | 0.13 (0.72) |
Any psychotherapy | 39 | 47.3 (6.5) | 22 | 33.0 (6.2) | 61 | 40.7 (5.0) | 2.98 (0.10) |
Adequate psychotherapy | 30 | 35.5 (5.8) | 19 | 30.9 (6.3) | 49 | 33.4 (4.5) | 0.32 (0.58) |
Effective coverage | 13 | 17.3 (4.3) | 22 | 34.5 (7.1) | 35 | 25.2 (4.2) | 5.36 (0.029)* |